Lupus Anticoagulant and Thrombosis Following Henoch-Schönlein Purpura

Pediatric Neurology

Volumn 36, Issue 5, 2007, Pages 345-347

  Abend, Nicholas S ^a   Licht, Daniel J ^a   Spencer, Charles H ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE; WARFARIN;

ADOLESCENT; ANAPHYLACTOID PURPURA; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HEADACHE; HUMAN; HYPERCOAGULABILITY; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADOLESCENT; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; PURPURA, SCHOENLEIN-HENOCH; SINUS THROMBOSIS, INTRACRANIAL;

EID: 34248193876     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.01.005     Document Type: Article

References (14)

1. Tizard E.J. Henoch-Schönlein purpura. Arch Dis Child 80 (1999) 380-383
2. Sebire G., Tabarki B., Saunders D.E., et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 128 (2005) 477-489
3. deVeber G., Andrew M., Adams C., et al. Cerebral sinovenous thrombosis in children. N Engl J Med 345 (2001) 417-423
4. Ravelli A., and Martini A. Antiphospholipid syndrome. Pediatr Clin North Am 52 (2005) 469-491
5. Mills J.A., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33 (1990) 1114-1121
6. Trapani S., Micheli A., Grisolia F., et al. Henoch Schönlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35 (2005) 143-153
7. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
8. Giron-Gonzalez J.A., Garcia del Rio E., Rodriguez C., Rodriguez-Martorell J., and Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31 (2004) 1560-1567
9. Monastiri K., Selmi H., Tabarki B., Yacoub M., Mahjoub T., and Essoussi A.S. Primary antiphospholipid syndrome presenting as complicated Henoch-Schönlein purpura. Arch Dis Child 86 (2002) 132-133
10. Garber M.E., Mohr B.W., and Calabrese L.H. Henoch-Schönlein purpura associated with anti-Ro (SSA) and antiphospholipid antibody syndrome. J Rheumatol 20 (1993) 1964-1966
11. Katayama I., Masuzawa M., Nishioka K., and Nishiyama S. Anticardiolipin antibody in Henoch-Schönlein purpura and related vascular disorders. Arch Dermatol Res 281 (1989) 296-298
12. Sokol D.K., McIntyre J.A., Short R.A., et al. Henoch-Schönlein purpura and stroke: antiphosphatidylethanolamine antibody in CSF and serum. Neurology 55 (2000) 1379-1381
13. Watanabe T., and Onda H. Henoch-Schönlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatr Nephrol 16 (2001) 458-459 discussion 460-2
14. Belman A.L., Leicher C.R., Moshe S.L., and Mezey A.P. Neurologic manifestations of Schöenlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 75 (1985) 687-692